Follow the Latest News from IMS
The 2nd Immune Effector Cell Therapies in Multiple Myeloma Workshop begins tomorrow Learn more here: http://ow.ly/M41950EEBEZ
There's still time to register for the @Myeloma_Society 2nd Immune Effector Cell Therapies in MM workshop. Meet in-person in #Boston or participate virtually May 7-8! Learn more here: http://ow.ly/M41950EEBEZ
.@Myeloma_Society is proud to unveil its new website! Check it out today: https://www.myelomasociety.org/
Breaking News: lde-cel (Abecma; idecabtagene vicleucel), approved by FDA for multiple myeloma.
This is the first CAR-T therapy for myeloma. Many patients have been waiting for this good news. @agarwalonc @BMS_Myeloma_US @bluebirdbio https://news.bms.com/news/corporate-financial/2021/U.S.-Food-and-Drug-Administration-Approves-Bristol-Myers-Squibbs-and-bluebird-bios-Abecma-idecabtagene-vicleucel-the-First-Anti-BCMA-CAR-T-Cell-Therapy-for-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx
. @Myeloma_Society has developed Recommendations for #Covid-19 #vaccination in patients with multiple myeloma (MM) and related conditions. http://ow.ly/oMq050DsOfC
Applications for the @Myeloma_Society and Paula and Rodger Riney Foundation Translational Research Grant are due on February 15! Learn more here: http://ow.ly/gzsL50CTkYj
Applications for the @Myeloma_Society Career Development Award are now due on 2/15/21! These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1
.@Myeloma_Society is proud to announce the "International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Grant." Applications are due 2/15/21. Learn more here: http://ow.ly/gzsL50CTkYj
Apply for the @Myeloma_Society Career Development Award due on 1/15/21! These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1
The deadline for the Career Development Award has been extended to January 15, 2021! Learn more here:
http://ow.ly/4VlS50Ck3U1
Apply for the @Myeloma_Society Career Development Award due on 11/15. These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1
Apply for the @Myeloma_Society Career Development Award due on 11/15. These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1
Past Newsletters
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
